News
Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health over the ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...
People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...
Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...
Amanda Bynes is starting a weight loss journey and turning to Ozempic for help. In a video shared to her Instagram Stories on ...
A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results